MARKET

SNYNF

SNYNF

Sanofi FR
OTCPK
83.60
NaN%
Closed 09:30 11/13 EST
OPEN
--
PREV CLOSE
83.60
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
98.26
52 WEEK LOW
79.45
MARKET CAP
99.63B
P/E (TTM)
19.12
1D
5D
1M
3M
1Y
5Y
1D
Sanofi Updates Infant Pompe Disease Study: What Investors Should Know
TipRanks · 15h ago
Sanofi's Biggest Moneymaker to Face Competition -- Market Talk
Dow Jones · 23h ago
Windward Bio Group IPO of 10.3M Shrs Prices at $17 Each
Dow Jones · 1d ago
Sanofi Discloses October 31, 2026 Share and Voting Rights Figures
TipRanks · 1d ago
Sanofi Updates Fabry Disease Study: What Investors Should Know
TipRanks · 1d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Compass Therapeutics (CMPX), Innate Pharma (IPHA) and Sanofi (OtherSNYNF)
TipRanks · 4d ago
Sanofi upgraded to Outperform from Neutral at BNP Paribas
TipRanks · 4d ago
Weekly Report: what happened at SNYNF last week (1102-1106)?
Weekly Report · 4d ago
More
About SNYNF
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA stock information, including OTCPK: SNYNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNYNF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNYNF stock methods without spending real money on the virtual paper trading platform.